• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (14)
    • Manifold roles of ?-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9.
    • Advanced atherosclerosis imaging by CT: Radiomics, machine learning and deep learning.
    • Alterations in glutamatergic and gabaergic ion channel activity in hippocampal neurons following exposure to the abused inhalant toluene.
    • Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    • Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients.
    • See All 14 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients.

Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients. Am Heart J. 2018 04; 198:84-90.

View in: PubMed

subject areas
  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Anticoagulants
  • Benzamides
  • Critical Illness
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Hospitalization
  • Humans
  • Incidence
  • Intention to Treat Analysis
  • Kaplan-Meier Estimate
  • Male
  • Primary Prevention
  • Prognosis
  • Proportional Hazards Models
  • Pulmonary Embolism
  • Pyridines
  • Risk Assessment
  • Survival Analysis
  • Treatment Outcome
  • Venous Thromboembolism

authors with profiles
  • Robert Harrington